Sun Pengling, Sleat David E, Lecocq Michèle, Hayman Alison R, Jadot Michel, Lobel Peter
Center for Advanced Biotechnology and Medicine and Department of Pharmacology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16590-5. doi: 10.1073/pnas.0807472105. Epub 2008 Oct 21.
Most newly synthesized proteins destined for the lysosome reach this location via a specific intracellular pathway. In the Golgi, a phosphotransferase specifically labels lysosomal proteins with mannose 6-phosphate (Man-6-P). This modification is recognized by receptors that target the lysosomal proteins to the lysosome where, in most cell types, the Man-6-P recognition marker is rapidly removed. Despite extensive characterization of this pathway, the enzyme responsible for the removal of the targeting modification has remained elusive. In this study, we have identified this activity. Preliminary investigations using a cell-based bioassay were used to follow a dephosphorylation activity that was associated with the lysosomal fraction. This activity was high in the liver, where endogenous lysosomal proteins are efficiently dephosphorylated, but present at a much lower level in the brain, where the modification persists. This observation, combined with an analysis of the expression of lysosomal proteins in different tissues, led us to identify acid phosphatase 5 (ACP5) as a candidate for the enzyme that removes Man-6-P. Expression of ACP5 in N1E-115 neuroblastoma cells, which do not efficiently dephosphorylate lysosomal proteins, significantly decreased the steady state levels of Man6-P glycoproteins. Analysis of ACP5-deficient mice revealed that levels of Man-6-P glycoproteins were highly elevated in tissues that normally express ACP5, and this resulted from a failure to dephosphorylate lysosomal proteins. These results indicate a central role for ACP5 in removal of the Man-6-P recognition marker and open up new avenues to investigate the importance of this process in cell biology and medicine.
大多数新合成的、 destined for the lysosome的蛋白质通过特定的细胞内途径到达该位置。在高尔基体中,一种磷酸转移酶用甘露糖6-磷酸(Man-6-P)特异性标记溶酶体蛋白。这种修饰被将溶酶体蛋白靶向溶酶体的受体识别,在大多数细胞类型中,Man-6-P识别标记会迅速被去除。尽管对该途径进行了广泛的表征,但负责去除靶向修饰的酶仍然难以捉摸。在本研究中,我们已经确定了这种活性。使用基于细胞的生物测定法进行的初步研究用于追踪与溶酶体部分相关的去磷酸化活性。这种活性在肝脏中很高,内源性溶酶体蛋白在肝脏中有效地去磷酸化,但在大脑中水平要低得多,在大脑中这种修饰持续存在。这一观察结果,结合对不同组织中溶酶体蛋白表达的分析,使我们确定酸性磷酸酶5(ACP5)是去除Man-6-P的酶的候选者。在不能有效地使溶酶体蛋白去磷酸化的N1E-115神经母细胞瘤细胞中表达ACP5,显著降低了Man6-P糖蛋白的稳态水平。对ACP5缺陷小鼠的分析表明,在正常表达ACP5的组织中,Man-6-P糖蛋白的水平高度升高,这是由于溶酶体蛋白去磷酸化失败所致。这些结果表明ACP5在去除Man-6-P识别标记中起核心作用,并为研究这一过程在细胞生物学和医学中的重要性开辟了新途径。 (注:原文中“destined for the lysosome”表述不太完整准确,推测完整意思可能是“大多数新合成的、注定要进入溶酶体的蛋白质” )